HK1146723A1 - (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them (r)-4-() - Google Patents

(r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them (r)-4-()

Info

Publication number
HK1146723A1
HK1146723A1 HK11100835.6A HK11100835A HK1146723A1 HK 1146723 A1 HK1146723 A1 HK 1146723A1 HK 11100835 A HK11100835 A HK 11100835A HK 1146723 A1 HK1146723 A1 HK 1146723A1
Authority
HK
Hong Kong
Prior art keywords
useful
treatment
heteroaryl
pharmaceutical compositions
compositions containing
Prior art date
Application number
HK11100835.6A
Other languages
English (en)
Inventor
Alessio Moriconi
Andrea Aramini
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Publication of HK1146723A1 publication Critical patent/HK1146723A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HK11100835.6A 2007-10-18 2011-01-27 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them (r)-4-() HK1146723A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07020396 2007-10-18
PCT/EP2008/064023 WO2009050258A1 (en) 2007-10-18 2008-10-17 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
HK1146723A1 true HK1146723A1 (en) 2011-07-08

Family

ID=40325746

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11100835.6A HK1146723A1 (en) 2007-10-18 2011-01-27 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them (r)-4-()

Country Status (19)

Country Link
US (1) US8133911B2 (xx)
EP (1) EP2201006B1 (xx)
JP (1) JP5374511B2 (xx)
CN (1) CN101827841B (xx)
AT (1) ATE501140T1 (xx)
AU (1) AU2008313669B2 (xx)
BR (1) BRPI0817824B8 (xx)
CA (1) CA2702307C (xx)
DE (1) DE602008005488D1 (xx)
DK (1) DK2201006T3 (xx)
ES (1) ES2361233T3 (xx)
HK (1) HK1146723A1 (xx)
HR (1) HRP20110406T1 (xx)
IL (1) IL205029A (xx)
PL (1) PL2201006T3 (xx)
PT (1) PT2201006E (xx)
RU (1) RU2475486C2 (xx)
SI (1) SI2201006T1 (xx)
WO (1) WO2009050258A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2166006A1 (en) * 2008-09-18 2010-03-24 Dompe' S.P.A. 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
EP3498269A1 (en) * 2017-12-12 2019-06-19 Dompé farmaceutici S.p.A. C5ar inhibitors for use in the treatment of chemotherapy-induced iatrogenic pain
CN115433143B (zh) * 2021-06-03 2023-10-13 中国科学院大连化学物理研究所 一种异噻唑啉酮类化合物的合成方法
EP4397306A1 (en) 2023-01-05 2024-07-10 Dompe' Farmaceutici S.P.A. C5ar1 inhibitors for use in the treatment of ocular mucous membrane pemphigoid and/or oral mucous membrane pemphigoid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9710002A (pt) * 1996-06-27 1999-08-10 Janssen Pharmaceutica Nv N-[4-(heteroarilmetil)fenil]-heteroarilaminas
ITMI20012025A1 (it) * 2001-09-28 2003-03-28 Dompe Spa Sali di ammonio quaternari di omega-amminoalchilammidi di acidi r 2-aril-propionici e composizioni farmaceutiche che li contengono
RU2458051C2 (ru) * 2005-11-24 2012-08-10 ДОМПЕ ФА.Р.МА С.п.А. (r)-арилалкиламинопроизводные и содержащие их фармацевтические композиции

Also Published As

Publication number Publication date
WO2009050258A1 (en) 2009-04-23
DE602008005488D1 (de) 2011-04-21
JP5374511B2 (ja) 2013-12-25
BRPI0817824B1 (pt) 2018-12-26
AU2008313669B2 (en) 2014-01-16
SI2201006T1 (sl) 2011-07-29
IL205029A0 (en) 2010-11-30
BRPI0817824B8 (pt) 2021-05-25
JP2011500643A (ja) 2011-01-06
BRPI0817824A2 (pt) 2015-03-31
RU2475486C2 (ru) 2013-02-20
US20100249198A1 (en) 2010-09-30
PT2201006E (pt) 2011-05-05
PL2201006T3 (pl) 2011-08-31
CN101827841A (zh) 2010-09-08
ATE501140T1 (de) 2011-03-15
ES2361233T3 (es) 2011-06-15
CN101827841B (zh) 2012-11-28
CA2702307A1 (en) 2009-04-23
IL205029A (en) 2014-09-30
CA2702307C (en) 2016-04-05
AU2008313669A1 (en) 2009-04-23
EP2201006B1 (en) 2011-03-09
RU2010119705A (ru) 2011-11-27
DK2201006T3 (da) 2011-06-27
HRP20110406T1 (hr) 2011-06-30
US8133911B2 (en) 2012-03-13
EP2201006A1 (en) 2010-06-30

Similar Documents

Publication Publication Date Title
WO2007060215A3 (en) (r)-arylkylamino derivatives and pharmaceutical compositions containing them
ZA200704824B (en) 2-Arylpropionic acid derivatives and pharmaceutical compositions containing them
HK1146723A1 (en) (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them (r)-4-()
BRPI0813271A2 (pt) Síntese regiosseletiva catalisada por cobre de benzimidazóis e azabenzimidazóis
WO2005090295A3 (en) 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
MX2011012366A (es) Mezclas fungicidas sinergeticas.
CL2012000311A1 (es) Compuestos derivados que contiene ciclos con 3 atomos de nitrogeno; utiles en el tratamiento de parasitosis en animales.
NZ593892A (en) Antibiotic compositions for the treatment of gram negative infections
MX2009007482A (es) Agentes antiparasitarios.
MX2009005054A (es) Disacaridos de beta 1,6 glucosamina funcionalizados y procedimiento para su preparacion.
MX2017008180A (es) Composicion detergente liquida.
PH12018502012A1 (en) Griseofulvin compound
ATE511501T1 (de) Übergangsmetallkatalysierte synthese von 2h- indazolen
MA33675B1 (fr) Composé indazole et pyrazolopyridine en tant qu'antagonistes du récepteur ccr1
TW200833641A (en) Polyacetylenic compounds
MX2012007539A (es) Derivados de hidroximoil-tetrazol fungicidas.
WO2007122792A3 (en) Biofilm formation inhibitor composition
UA118269C2 (uk) Промисловий спосіб синтезу уліпристалу ацетату і його 4'-ацетильного аналога
MX2012007540A (es) Derivados de hidroximoil-tetrazol fungicidas.
NO20061721L (no) Amidiner og derivater derav og farmasoytiske sammensetninger som inneholder disse
PH12018500020A1 (en) Novel imide derivatives and use thereof as medicine
BR112017008533A2 (pt) melhorias em ou relacionadas com os compostos orgânicos
Ivanets et al. Comparison of extraction ability of 18-term crown-ethers in relation to cesium
TH76306A (th) อนุพันธ์เตตระอะซาเบนโซ [e] อะซูลีนและอะนาลอกของพวกมัน
Lee et al. Design of Wearable Robot for Motion Range of Upper-Limb-Part 1